Usp18 Expression in CD169(+) Macrophages is Important for Strong Immune Response after Vaccination with VSV-EBOV

Ebola virus epidemics can be effectively limited by the VSV-EBOV vaccine (Ervebo) due to its rapid protection abilities; however, side effects prevent the broad use of VSV-EBOV as vaccine. Mechanisms explaining the efficient immune activation after single injection with the VSV-EBOV vaccine remain m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Vaccines (Basel)
Main Authors: Friedrich, Sarah-Kim, Schmitz, Rosa, Bergerhausen, Michael, Lang, Judith, Cham, Lamin B., Duhan, Vikas, Häussinger, Dieter, Hardt, Cornelia, Addo, Marylyn, Prinz, Marco, Asano, Kenichi, Lang, Philipp Alexander, Lang, Karl Sebastian
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7157200/
https://ncbi.nlm.nih.gov/pubmed/32210083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines8010142
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados